Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAFF interacting protein (pseudogene) is a gene annotated on the human Y chromosome (Y:11,153,858-11,159,013 reverse strand) whose sequence is homologous or related to protein-coding genes but is considered a *pseudogene*, meaning it does not produce a functional protein[1]. It is not an established therapeutic target, lacks detectable protein product, and is unlikely to be relevant for structured therapeutic, pharmacological, or biomarker analyses. If you are seeking information about the functional **MAFF protein (MAF BZIP transcription factor F)**, that is a distinct entity: a basic leucine zipper (bZIP) transcription factor with roles in gene regulation, stress response, and reproductive biology[5][3]. ENSG00000278212 does not encode this protein. **Note:** - If your intent was to find information on the protein that interacts with MAFF, or the canonical MAFF gene/protein itself, you should refer to the functional MAFF gene (e.g., ENSG00000184182). - This entry (ENSG00000278212) is flagged as *incorrect* for pharmacological, target, or biomarker context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAFF interacting protein (pseudogene).